Appointment booking for Dr. Harvey Azarva, MD is currently not available.Dr. Harvey Azarva, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Harvey Azarva, MD is a Internist in Melrose Park, PA with over 18 years of experience. What is your opinion of Dr. Harvey Azarva, MD? Rate this provider below so other people can make informed decision.
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Harvey Azarva, MD has received over $9,762 which includes payments from the following companies:
$1,414.32 from Novo Nordisk Inc
$1,387.48 from LILLY USA, LLC
$1,131.83 from AstraZeneca Pharmaceuticals LP
$1,124.56 from GlaxoSmithKline, LLC.
$981.64 from sanofi-aventis U.S. LLC
$597.07 from Takeda Pharmaceuticals America, Inc.
$496.79 from Janssen Pharmaceuticals, Inc
$440.22 from Merck Sharp & Dohme Corporation
$290.48 from Pfizer Inc.
$289.48 from Boehringer Ingelheim Pharmaceuticals, Inc.
$196.11 from AbbVie, Inc.
$193.45 from Shire North American Group Inc
$137.24 from Eisai Inc.
$131.85 from Becton, Dickinson and Company
$119.01 from Kowa Pharmaceuticals America, Inc.
$113.91 from VIVUS, Inc.
$113.80 from Abbott Laboratories
$108.62 from Gemini Laboratories, LLC
$95.33 from MannKind Corporation
$44.75 from Allergan Inc.
Payments received by Dr. Harvey Azarva, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!